BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9889035)

  • 1. Thrombocytosis in women with vulvar carcinoma.
    Lavie O; Comerci G; Daras V; Bolger BS; Lopes A; Monaghan JM
    Gynecol Oncol; 1999 Jan; 72(1):82-6. PubMed ID: 9889035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (A Gynecologic Oncology Group study).
    Hernandez E; Heller PB; Whitney C; Diana K; Delgado G
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):328-32. PubMed ID: 7835768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
    Shimada H; Oohira G; Okazumi S; Matsubara H; Nabeya Y; Hayashi H; Takeda A; Gunji Y; Ochiai T
    J Am Coll Surg; 2004 May; 198(5):737-41. PubMed ID: 15110807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
    Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
    Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor anemia and thrombocytosis in patients with vulvar cancer.
    Hefler L; Mayerhofer K; Leibman B; Obermair A; Reinthaller A; Kainz C; Tempfer C
    Tumour Biol; 2000; 21(5):309-14. PubMed ID: 10940827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
    Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
    Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of thrombocytosis in renal cell carcinoma.
    Bensalah K; Leray E; Fergelot P; Rioux-Leclercq N; Tostain J; Guillé F; Patard JJ
    J Urol; 2006 Mar; 175(3 Pt 1):859-63. PubMed ID: 16469566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma.
    Lu CC; Chang KW; Chou FC; Cheng CY; Liu CJ
    Oral Oncol; 2007 Mar; 43(3):283-8. PubMed ID: 16920387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis as a prognostic factor in endometrial carcinoma.
    Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
    Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of thrombocytosis in renal cell carcinoma patients.
    Inoue K; Kohashikawa K; Suzuki S; Shimada M; Yoshida H
    Int J Urol; 2004 Jun; 11(6):364-7. PubMed ID: 15157203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical surgery for T1 and T2 squamous cell carcinoma of the vulva through separate incisions.
    Khobjai A; Srisomboon J; Charoenkwan K; Phongnarisorn C; Suprasert P; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S75-81. PubMed ID: 17722321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
    Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytosis as a prognostic factor in women with cervical cancer.
    Lopes A; Daras V; Cross PA; Robertson G; Beynon G; Monaghan JM
    Cancer; 1994 Jul; 74(1):90-2. PubMed ID: 8004588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
    Landrum LM; Skaggs V; Gould N; Walker JL; McMeekin DS
    Gynecol Oncol; 2008 Mar; 108(3):584-90. PubMed ID: 18155755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
    Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM
    Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytosis in advanced epithelial ovarian cancer.
    Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
    J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.